Sildenafil citrate use and the incidence of nonarteritic anterior ischemic optic neuropathy.

International Journal of Clinical Practice
L GorkinR Siegel

Abstract

Nonarteritic anterior ischemic optic neuropathy (NAION) has been reported rarely in men after taking sildenafil or other phosphodiesterase 5 inhibitors for erectile dysfunction (ED). The incidence of NAION in men receiving sildenafil treatment for ED was estimated using pooled safety data from global clinical trials and European observational studies. Based on clinical trial data in more than 13,000 men and on more than 35,000 patient-years of observation in epidemiologic studies, we estimated an incidence of 2.8 cases of NAION per 100,000 patient-years of sildenafil exposure. This is similar to estimates reported in general US population samples (2.52 and 11.8 cases per 100,000 men aged >or=50 years). The data cited herein do not suggest an increased incidence of NAION in men who took sildenafil for ED.

References

Dec 15, 1994·American Journal of Ophthalmology·S S HayrehC R Long
Mar 1, 1994·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·L N Johnson, A C Arnold
Dec 15, 1993·American Journal of Ophthalmology·R M Burde
Jan 1, 1997·American Journal of Ophthalmology·M G HattenhauerD T Gray
Sep 5, 2002·American Journal of Ophthalmology·Nancy J NewmanUNKNOWN Ischemic Optic Neuropathy Decompression Trial Research Group
Oct 3, 2002·International Journal of Clinical Pharmacology and Therapeutics·A BoshierS A W Shakir
Nov 5, 2002·Urology·Harin Padma-nathanFrancesco Montorsi
May 9, 2003·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Diane Tran, Laurence Guy Howes
Apr 20, 2004·Current Opinion in Neurology·Janet C RuckerNancy J Newman
Aug 2, 2005·The American Journal of Cardiology·Murray A MittlemanDale B Glasser

❮ Previous
Next ❯

Citations

Nov 8, 2008·Current Diabetes Reports·David Price, Geoffrey Hackett
Oct 20, 2007·The British Journal of Ophthalmology·Helen V Danesh-Meyer, Leonard A Levin
Jun 13, 2008·Pharmacy World & Science : PWS·Huang-Chi ChenCheng-Yuan Wang
Jun 6, 2008·International Journal of Impotence Research·M J Thurtell, R L Tomsak
Jun 2, 2007·Expert Opinion on Drug Metabolism & Toxicology·Antonio AversaGiuseppe M C Rosano
Nov 2, 2014·The Journal of Sexual Medicine·Ulka B CampbellRobert F Reynolds
Nov 3, 2010·Optometry : Journal of the American Optometric Association·Kiersten NelsonDax Gay
Mar 5, 2010·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Rinat KehatBrenda Connors
Nov 7, 2007·The Urologic Clinics of North America·Allen D SeftelStanley E Althof
Jul 25, 2009·International Journal of Clinical Practice·R SadovskyS Sorsaburu
Jul 25, 2009·Clinical & Experimental Ophthalmology·Nathan M Kerr, Helen V Danesh-Meyer
Jul 28, 2007·International Journal of Clinical Practice·W J G Hellstrom
Jul 23, 2013·International Journal of Clinical Practice·W B SmithW J Hellstrom
Aug 28, 2014·Acta Ophthalmologica·Andrzej GrzybowskiFelix Tonagel
Apr 15, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ana PenedonesFrancisco Batel Marques
Jan 11, 2014·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Alberto Galvez-Ruiz, Nawal Arishi
Jun 9, 2006·International Journal of Impotence Research·E R SchwarzS Rosanio
Dec 22, 2006·International Journal of Impotence Research·S Doggrell
Jun 29, 2012·Korean journal of urology·Hyun Hwan Sung, Sung Won Lee
Dec 4, 2008·Clinical Neuropharmacology·Muhammad U FarooqMounzer Y Kassab
Jan 10, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Alan M Laties
Nov 18, 2009·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Min-Yong LowHwee-Ling Koh
Apr 17, 2010·Cardiology in Review·Joe R Anderson, James J Nawarskas
Aug 3, 2006·Nature Reviews. Drug Discovery·Hossein A GhofraniFriedrich Grimminger
May 8, 2019·Investigative Ophthalmology & Visual Science·Alon ZahaviNitza Goldenberg-Cohen
Jul 3, 2018·Asia-Pacific Journal of Ophthalmology·Leanne Stunkel, Gregory P Van Stavern
Oct 9, 2013·Current Opinion in Ophthalmology·Ugur E Altiparmak
Jun 5, 2012·Pharmacological Reviews·Lyn R Frumkin
Aug 23, 2019·Expert Opinion on Drug Safety·Murat Gul, Ege Can Serefoglu
Aug 13, 2020·International Journal of Retina and Vitreous·Natasha Ferreira Santos da CruzEduardo A Novais
Aug 12, 2020·Vestnik oftalmologii·O D OstroumovaL K Moshetova

❮ Previous
Next ❯

Software Mentioned

Revatio

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.